Evidence map›Paper›PMID 37365267›Full record

ArticleNature biomedical engineering2023

Generation of functionally distinct T-cell populations by altering the viscoelasticity of their extracellular matrix.

Kwasi Adu-Berchie, Yutong Liu, David K Y Zhang, Benjamin R Freedman, Joshua M Brockman, Kyle H Vining, Bryan A Nerger, Andrea Garmilla, David J Mooney

Open access · greenAbstract read
In one paragraph

Article in Nature biomedical engineering, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 1 pooled it
22.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. High-Density Type I Collagen Promotes IFN-γAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Viscoelastic Niches Shape γδ T-Cell Phenotype and Effector Function.bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Mechanomedicine.Nature reviews bioengineering · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Kwasi Adu-Berchie *John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.ORCID 0000-0002-1959-6794
Yutong Liu *John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.ORCID 0000-0001-5683-5451
David K Y ZhangJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.ORCID 0000-0002-6999-6454
Benjamin R FreedmanJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.
Joshua M BrockmanJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.ORCID 0000-0003-2775-3478
Kyle H ViningJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.ORCID 0000-0002-4009-879X
Bryan A NergerJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.ORCID 0000-0002-5702-1844
Andrea GarmillaHarvard Medical School, Boston, MA, USA.
David J MooneyJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA. mooneyd@seas.harvard.edu.ORCID 0000-0001-6299-1194
Harvard University · US

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Medical Scientist Training ProgramT32GM144273 · NIGMS · HARVARD MEDICAL SCHOOL · PI David Shumway Jones, Jacqueline A. Lees · 2022 to 2026
$14.7M
Organ Design and Engineering Training Program (ODET Program)T32EB016652 · NIBIB · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 2014 to 2023
$3.5M
Viscoelasticity and T Cell ProductionR01CA276459 · NCI · HARVARD UNIVERSITY · PI David J Mooney · 2023 to 2026
$2.4M
Scaffolds mimicking antigen presenting cellsR01FD006589 · FDA · HARVARD UNIVERSITY · PI MOONEY, DAVID J · 2018 to 2020
$1.8M
Supplement Multifunctional Tough Adhesive Hydrogels to Recruit, Expand, and Deliver Tendon Cells During Aging and InjuryR00AG065495 · NIA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Benjamin Ross Freedman · 2023 to 2026
$842k
Investigating mechanical regulation of nephrogenesis using viscoelastic biomaterials and kidney organoidsF32DK134115 · NIDDK · HARVARD UNIVERSITY · PI NERGER, BRYAN · 2022 to 2023
$127k
FDA HHS R01 FD006589NCI NIH HHS R01 CA276459NIA NIH HHS R00 AG065495NIBIB NIH HHS T32 EB016652NIDDK NIH HHS F32 DK134115NIGMS NIH HHS T32 GM007753NIGMS NIH HHS T32 GM144273Wellcome Trust
6 · The paper itself

Abstract

The efficacy of adoptive T-cell therapies largely depends on the generation of T-cell populations that provide rapid effector function and long-term protective immunity. Yet it is becoming clearer that the phenotypes and functions of T cells are inherently linked to their localization in tissues. Here we show that functionally distinct T-cell populations can be generated from T cells that received the same stimulation by altering the viscoelasticity of their surrounding extracellular matrix (ECM). By using a model ECM based on a norbornene-modified collagen type I whose viscoelasticity can be adjusted independently from its bulk stiffness by varying the degree of covalent crosslinking via a bioorthogonal click reaction with tetrazine moieties, we show that ECM viscoelasticity regulates T-cell phenotype and function via the activator-protein-1 signalling pathway, a critical regulator of T-cell activation and fate. Our observations are consistent with the tissue-dependent gene-expression profiles of T cells isolated from mechanically distinct tissues from patients with cancer or fibrosis, and suggest that matrix viscoelasticity could be leveraged when generating T-cell products for therapeutic applications.

Indexed as

Extracellular MatrixT-LymphocytesCollagen Type IFibrosisHumansSignal TransductionCollagen Type I

Identifiers

PMID37365267
PMCPMC10749992
OpenAlexW4382055553

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.